Medicare may begin to cover renal denervation with Medtronic’s Symplicity device by October, which could drive coverage among ...

The stock's fall snapped a two-day winning streak.

Wedmont Private Capital boosted its holdings in Medtronic plc (NYSE:MDT – Free Report) by 20.9% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC ...

Brookstone Capital Management lifted its stake in shares of Medtronic plc (NYSE:MDT – Free Report) by 11.4% during the 4th quarter, according to the company in its most recent filing with the ...

Medtronic is picking up steam with recent product launches, and its balance sheet is a fortress. Read more about MDT stock ...

Medtronic will be the exclusive U.S. distributor of Contego Medical’s portfolio, which includes a carotid stent system and ...

Medtronic (NYSE: MDT) announced today that it received CE mark approval for its BrainSense adaptive deep brain stimulation ...

Medtronic says CMS is opening a national coverage analysis on renal denervation (RDN) procedures for patients with ...

For not just years but decades, Medtronic (NYSE: MDT) has proven to be a reliable dividend growth stock to own. The medical ...

Medtronic Vietnam and the University Medical Center Ho Chi Minh City (UMC HCMC) have signed their fourth Memorandum of ...

While deep-brain stimulation therapy has been available for people with Parkinson’s disease for decades, Medtronic has now ...

Medtronic offers solid income potential with a 3.5% dividend yield. Read why MDT stock’s forward P/E ratio signals possible ...